Montelukast Prescribing at THE WELLSPRING SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
586
Total Quantity
13.3K
NHS Cost
£647
vs National Avg
-14.4%
THE WELLSPRING SURGERY prescribed 586 items of Montelukast over the last 12 months at a cost of £647 to the NHS. This is 14.4% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
51
Jun 2026
36
Jun 2026
44
Jun 2026
42
Jun 2026
48
Jun 2026
41
Jun 2026
44
Jun 2026
47
Jun 2026
49
Jun 2026
59
Jun 2026
72
Jun 2026
53
Prescribing Details
| Total Items | 586 |
|---|---|
| Total Quantity | 13,347 |
| Total NHS Cost | £647 |
| Presentations | 4 different forms |
| vs National Average | -14.4% |
Montelukast Prescribing Comparison
| This practice | 586 items |
|---|---|
| National average per practice | 685 items |
| Difference | -14.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.